HFpEF

BOSTON and SHANGHAI — September 28, 2026 Eccogene announced that it has received a $50 million milestone payment from...

HEIDELBERG, Germany — August 25, 2026 Revier Therapeutics has officially launched operations following the closing of a €6 million...

Boston, Mass. & Liège, Belgium, August 10, 2026 Curium announced the completion of its acquisition of Abscint SA, a...

Chapel Hill, N.C., August 10, 2026 Tenax Therapeutics, Inc. announced topline results from the Phase 3 LEVEL clinical trial...

NORTH CHICAGO, Illinois, USA – June 8, 2026 AbbVie has announced the presentation of new clinical and translational research...

ENCINITAS, California, USA & WROCLAW, Poland – June 8, 2026 Vasa Therapeutics, a clinical-stage biotechnology company focused on therapies...

MONTREAL, Canada, May 29, 2026 Leica Biosystems, a global leader in anatomic and digital pathology solutions, and CellCarta, a...

CHICAGO, Ill., May 29, 2026 Cardiosense has achieved a major regulatory milestone with the U.S. Food and Drug Administration...

BOULDER, Colo., May 7, 2026 Edgewise Therapeutics reported first quarter 2026 financial results while highlighting major progress across its...